Jove
Visualize
Contact Us

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort.

ESMO open·2025
Same author

Prognostic value of EndoPredict test in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative primary breast cancer screened for the randomized, double-blind, phase III UNIRAD trial.

ESMO open·2024
Same author

[Lipofilling in the management of breast cancer: An update based on a literature review and national and international guidelines].

Gynecologie, obstetrique, fertilite & senologie·2023
Same author

Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.

British journal of cancer·2023
Same author

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy.

ESMO open·2022
Same author

Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188].

European journal of cancer (Oxford, England : 1990)·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 25, 2026

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
05:05

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Published on: November 29, 2018

The inflammatory breast: management, decision-making algorithms, therapeutic principles.

M Boisserie-Lacroix1, M Debled, C Tunon de Lara

  • 1Senology Unit, Medical Imaging Department, Institut Bergonié, 229, rue de l'Argonne, 33076 Bordeaux cedex, France. boisserie-lacroix@bergonie.org

Diagnostic and Interventional Imaging
|February 7, 2012
PubMed
Summary

Inflammatory breast syndrome, often infectious, requires diagnostic tests like ultrasonography for accurate diagnosis. Early detection is crucial, as imaging can differentiate benign conditions from inflammatory breast cancer, ensuring timely oncologic management.

Related Experiment Videos

Last Updated: May 25, 2026

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
05:05

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Published on: November 29, 2018

Area of Science:

  • Oncology
  • Radiology
  • Infectious Diseases

Background:

  • Inflammatory breast syndrome is a rare but serious breast emergency.
  • Most cases are benign and infectious, presenting with clear clinical signs.
  • Clinical examination alone is insufficient for diagnosis, necessitating further investigation.

Purpose of the Study:

  • To highlight the diagnostic challenges in inflammatory breast syndrome.
  • To emphasize the role of imaging in differentiating benign from malignant conditions.
  • To underscore the importance of prompt oncologic management.

Main Methods:

  • Review of clinical presentation and diagnostic imaging.
  • Comparison of mammography and ultrasonography in breast inflammation.
  • Evaluation of treatment pathways for benign versus malignant etiologies.

Main Results:

  • Ultrasonography is superior to mammography in detecting abscesses and malignant tumors in inflammatory breast conditions.
  • Benign inflammatory conditions typically resolve with medical treatment.
  • Delaying oncologic management due to presumed benign etiology can have severe consequences.

Conclusions:

  • Accurate diagnosis through imaging is critical for appropriate patient management.
  • Ultrasonography plays a vital role in differentiating inflammatory breast conditions.
  • Prompt oncologic assessment is essential to avoid delays in managing potentially malignant inflammatory breast cancer.